CompoAtlas

Ashwagandha

Food supplement declared in France, declaration No 2022-2-9, decision dated 1 February 2022

Ashwagandha (Stimium) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Stimium
Food business operator placing the product on the market
LABORATOIRES STIMIUM
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélules
Directions for use
1 gélule le soir au coucher
Intended populations
Homme, Femme
Objectives stated by the manufacturer (these are not authorised claims)
Mémoire, Immunité, Concentration

Declaration 322460, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineExtrait sec aqueux300 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Carbonate de calciumCalcium2,500 mg800 mg

Additives

E460, E470b

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Ne pas dépasser la dose journalière recommandé. Tenir hors de la portée des jeune enfants

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : Stimium

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line